Literature DB >> 16500108

Cyclotron production of 64Cu by deuteron irradiation of 64Zn.

K Abbas1, J Kozempel, M Bonardi, F Groppi, A Alfarano, U Holzwarth, F Simonelli, H Hofman, W Horstmann, E Menapace, L Lesetický, N Gibson.   

Abstract

The short-lived (12.7h half-life) (64)Cu radioisotope is both a beta(+) and a beta(-) emitter. This property makes (64)Cu a promising candidate for novel medical applications, since it can be used simultaneously for therapeutic application of radiolabelled biomolecules and for diagnosis with PET. Following previous work on (64)Cu production by deuteron irradiation of natural zinc, we report here the production of this radioisotope by deuteron irradiation of enriched (64)Zn. In addition, yields of other radioisotopes such as (61)Cu, (67)Cu, (65)Zn, (69m)Zn, (66)Ga and (67)Ga, which were co-produced in this process, were also measured. The evaporation code ALICE-91 and the transport code SRIM 2003 were used to determine the excitation functions and the stopping power, respectively. All the nuclear reactions yielding the above-mentioned radioisotopes were taken into account in the calculations both for the natural and enriched Zn targets. The experimental and calculated yields were shown to be in reasonable agreement. The work was carried out at the Scanditronix MC-40 Cyclotron of the Institute for Health and Consumer Protection of the Joint Research Centre of the European Commission (Ispra site, Italy). The irradiations were carried out with 19.5 MeV deuterons, the maximum deuteron energy obtainable with the MC-40 cyclotron.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500108     DOI: 10.1016/j.apradiso.2005.12.021

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  7 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Non-standard PET radionuclides: time to get ready for new clinical PET strategies.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02       Impact factor: 9.236

3.  A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  Dalton Trans       Date:  2011-03-25       Impact factor: 4.390

Review 4.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

5.  Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes.

Authors:  Richard Ting; Todd A Aguilera; Jessica L Crisp; David J Hall; William C Eckelman; David R Vera; Roger Y Tsien
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

6.  Development of a generic approach to native metalloproteomics: application to the quantitative identification of soluble copper proteins in Escherichia coli.

Authors:  Ana-Maria Sevcenco; Gerard C Krijger; Martijn W H Pinkse; Peter D E M Verhaert; Wilfred R Hagen; Peter-Leon Hagedoorn
Journal:  J Biol Inorg Chem       Date:  2009-02-11       Impact factor: 3.358

7.  Early Evaluation of Copper Radioisotope Production at ISOLPHARM.

Authors:  Francesca Borgna; Michele Ballan; Chiara Favaretto; Marco Verona; Marianna Tosato; Michele Caeran; Stefano Corradetti; Alberto Andrighetto; Valerio Di Marco; Giovanni Marzaro; Nicola Realdon
Journal:  Molecules       Date:  2018-09-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.